BSE filing, NSE: AVONLIFE. Summary written from the filing by ALFA Finder's alert engine.
Kobo Biotech Ltd: key numbers
- Share price
- ₹3.94
- Market cap
- ₹9.39 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-4.93 Cr
- P/E (TTM)
- -1.9×Sector 46.1×
- Promoter holding
- 44.95%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kobo Biotech Ltd
All →Kobo Biotech Annual General Meeting
Kobo Biotech Ltd conducted its 31st Annual General Meeting on July 24, 2026. Shareholders passed the ordinary resolution for adoption of annual accounts and reports.
Kobo Biotech Insolvency Petition
Kobo Biotech reports that Beaufond Industries failed to implement the NCLT-approved resolution plan by the July 10 deadline. A Monitoring Committee meeting is convened for further action.
- Execution
- Implementation was due by 10 July 2026
Kobo Biotech Annual Report
Kobo Biotech Ltd submitted its Annual Report for FY 2023-24. The 31st AGM is scheduled for July 24, 2026.
Kobo Biotech Insolvency Petition
NCLT approved Beaufond Industries' ₹70.11 Crore resolution plan for Kobo Biotech. The plan involves a merger, fresh equity issuance, and settlement of all existing liabilities.
- Value
- ₹70.11 Cr
Kobo Biotech Insolvency Petition
NCLT approved Beaufond Industries' ₹70.11 Crore resolution plan for Kobo Biotech Limited. The plan ensures business continuity through debt settlement and restructuring.
- Value
- ₹70.11 Cr
- Execution
- 60 days
Kobo Biotech Debt & Borrowing
Kobo Biotech Limited confirmed it does not meet the criteria for classification as a 'Large Corporate' (LC) as of March 31, 2026. This disclosure follows SEBI's framework regarding debt securities issuance by large entities.
Other insolvency petition announcements
All →BIL Vyapar Insolvency Petition
Bil Vyapar Ltd, under CIRP, intimated its 21st Committee of Creditors meeting for October 29, 2026. No monetary amount or resolution plan details are disclosed.
Polycab India Insolvency Petition
NCLAT directed MSCI not to delist Polycab from its Index pending the insolvency appeal order. The interim direction preserves index inclusion during the CIRP appeal.
Premier Insolvency Petition
Premier Limited (in CIRP) intimated that its 21st CoC meeting was rescheduled from December 11 to December 12, 2025. The Resolution Professional filed this under SEBI Regulation 30 for exchange record.
CMI Insolvency Petition
CMI Limited, a Corporate Debtor under CIRP, intimated its 49th Committee of Creditors meeting scheduled for 27 October 2026. No resolution details are disclosed.
DPSC Insolvency Petition
DPSC Limited (under CIRP) reported that its 8th CoC meeting approved all remaining agenda items except consultancy fees to a related party. No new monetary value or resolution plan outcome is disclosed.
Shrenik Insolvency Petition
Shrenik Limited's resolution professional disclosed the third Committee of Creditors meeting under CIRP, scheduled for 22 October 2026. The filing is procedural and includes no monetary amount.